regulatory approval
regulatory approval
EMA Approves 10 New Life-Changing Medicines!
BIOT
📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉
Overcoming the Biosimilar Bottleneck: The Solution to Medicine Shortages in Europe
BIOT
🔍 Supply chain shortages in Europe worsened by pharmaceutical companies not licensing biosimilars. 🌍 A pan-European license could improve access. 💡 UK regulator encourages innovation. ⚙️ QTL technology can increase availability.
Alvotech’s Groundbreaking AVT03 Study: A Game-Changer in Osteoporosis Treatment
BIOT
🔬 Alvotech SA reported positive results from a study of AVT03, a biosimilar candidate for osteoporosis treatment.
